Showing results (511-520 of 620) with videos related to

Sort By:
Pageof 62
Plos One|March 19, 2013
Fatty aldehydes in cyanobacteria are a metabolically flexible precursor for a diversity of biofuel productsBrett K Kaiser, Michael Carleton, Jason W Hickman, et al.
Nature Communications|May 24, 2012
Closed network growth of fullerenesPaul W Dunk, Nathan K Kaiser, Christopher L Hendrickson, et al.
Ophthalmology. Retina|May 4, 2019
Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension StudyPeter K Kaiser, Michael Singer, Michael Tolentino, et al.
Ophthalmology. Retina|January 16, 2026
Swept-Source OCT and OCTA B-Scan Analysis of Inflammatory Retinal Vascular Changes: Quantitative and Qualitative AssessmentYuka Mizuno, Sunil K Srivastava, Sandeep Singh, et al.
JAMA Ophthalmology|November 24, 2021
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare MapArshad M Khanani, Marco A Zarbin, Mark R Barakat, et al.
Investigative Ophthalmology & Visual Science|June 17, 2022
The Association of Fluid Volatility With Subretinal Hyperreflective Material and Ellipsoid Zone Integrity in Neovascular AMDJustis P Ehlers, Nikhil Patel, Peter K Kaiser, et al.
The British Journal of Ophthalmology|March 5, 2017
A retrospective study of the influence of the vitreomacular interface on macular oedema secondary to retinal vein occlusionRishi P Singh, Karishma A Habbu, Rumneek Bedi, et al.
Archives of Neurology|August 1, 1987
Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisoneM H Brooke, G M Fenichel, R C Griggs, et al.
Ophthalmology. Retina|September 6, 2023
Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF TherapyAndrei Szigiato, Nitesh Mohan, Katherine E Talcott, et al.
Pageof 62